fizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations.
h/t A Deplorable Neanderthal
Views:
A fine selection of independent media sources
fizer raised its forecast for annual sales of its COVID vaccine to $34 billion on demand for Omicron-targeted boosters, helping allay some investor worries over growth for the vaccinations.
h/t A Deplorable Neanderthal